Christopher Heery - 05 May 2023 Form 4 Insider Report for Arcellx, Inc. (ACLX)

Reporting relationship: Chief Medical Officer
Issuer ticker: ACLX
Reported as of: 05 May 2023
Net transaction value: -$54,002
SEC form: 4
Accepted by SEC: 08 May 2023, 18:50:36 UTC
Prior SEC filing: 05 May 2023
Next SEC filing: 11 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Rami Elghandour, as Attorney-in-Fact

Key filing fact

Christopher Heery filed Form 4 for Arcellx, Inc. (ACLX) on 08 May 2023.

Key facts

This page summarizes Christopher Heery's Form 4 filing for Arcellx, Inc. (ACLX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 May 2023, 18:50.

Change

Previous filing in this sequence was filed on 05 May 2023.
Current net transaction value: -$54,002.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACLX transaction

Common Stock

Sale

Transaction value: $54,002
Shares: -1,200
Change %: -10%
Price: $45.00
Shares after: 10,492
Date: 05 May 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 30, 2022.

Footnote F2

Represents the weighted average share price of an aggregate total of 1,200 shares sold in the price range of $45.00 to $45.02 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.